Pembrolizumab in advanced melanoma: Added benefit for certain patients
Monday, November 23, 2015 - 13:00
in Health & Medicine
Certain adults with pretreatment have fewer side effects under pembrolizumab. Treatment-naive patients without tumor mutation survive longer and have better social participation, report reviewers.